Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer

• Váldodahkkit: Tudor Moisoiu (Dahkki), Mihnea P. Dragomir (Dahkki), Stefania D. Iancu (Dahkki), Simon Schallenberg (Dahkki), Giovanni Birolo (Dahkki), Giulio Ferrero (Dahkki), Dan Burghelea (Dahkki), Andrei Stefancu (Dahkki), Ramona G. Cozan (Dahkki), Emilia Licarete (Dahkki), Alessandra Allione (Dahkki), Giuseppe Matullo (Dahkki), Gheorghita Iacob (Dahkki), Zoltán Bálint (Dahkki), Radu I. Badea (Dahkki), Alessio Naccarati (Dahkki), David Horst (Dahkki), Barbara Pardini (Dahkki), Nicolae Leopold (Dahkki), Florin Elec (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Bladder cancer (BC) has the highest per-patient cost of all cancer types. Hence, we aim to develop a non-invasive, point-of-care tool for the diagnostic and molecular stratification of patients with BC based on combined microRNAs (miRNAs) and surface-enhanced Raman spectroscopy (...